Table of Contents

1  Individualized Assessment for Percutaneous or  Surgical-Based Revascularization
2  Evidence-Based Interventional Practice
3  Diabetes
4  Noninvasive Evaluation: Functional Testing,Multidetector Computed Tomography, and Stress  Cardiac MRI
5  Intracoronary Pressure and Flow Measurements
6  Contrast-Induced Acute Kidney Injury and the Role of Chronic Kidney Disease in Percutaneous Coronary Intervention
7  Radiation Safety During Cardiovascular  Procedures
8  Coronary and Valvular Intervention Prior to  Noncardiac Surgery
9  Sex and Ethnicity Issues in Interventional  Cardiology
10  Platelet Inhibitor Agents
11  Anticoagulation in Percutaneous Coronary  Intervention
12  Thrombolytic Intervention
13  Other Adjunctive Drugs for Coronary  Intervention: Beta-Blockers, Calcium-Channel Blockers, and Angiotensin-Converting Enzyme Inhibitors
14  Coronary Stenting: Practical Considerations,  Equipment Selection, Tips and Caveats
15  Coronary Stenting
16  Bioresorbable Coronary Scaffolds
17  Drug-Eluting Balloons
18  Elective Intervention for Stable Angina or Silent Ischemia
19  Intervention for Non-ST-Segment Elevation Acute Coronary Syndromes
20  Percutaneous Coronary Intervention in Acute  ST-Segment Elevation Myocardial Infarction
21  Post-Percutaneous Coronary Intervention Hospitalization, Length of Stay, and Discharge  Planning
22  Interventions in Cardiogenic Shock
23  Bifurcations and Branch Vessel Stenting
24  Percutaneous Coronary Intervention for  Unprotected Left Main Coronary Artery Stenosis
25  Complex and Multivessel Percutaneous Coronary Intervention
26  Intervention for Coronary Chronic Total  Occlusions
27  Bypass Graft Intervention
28  The Thrombus-Containing Lesion
29  Complications of Percutaneous Coronary  Intervention
30  Periprocedural Myocardial Infarction and  Embolism-Protection Devices
31  Access Management and Closure Devices
32  Transradial Access for Cardiovascular  Catheterization and Intervention
33  Role of the Cardiac Surgeon and the Heart Team
34  Restenosis
35  Role of Adjunct Devices: Atherectomy, Cutting Balloon, and Laser
36  Supported Percutaneous Intervention
37  Regional Centers of Excellence for the Care of Patients With Acute Ischemic Heart Disease
38  Diagnosis and Treatment of Coronary  Microvascular Disease
39  Lower Extremity Interventions
40  Upper Extremities and Aortic Arch
41  Chronic Mesenteric Ischemia: Diagnosis and  Intervention
42  Renal Artery Stenosis
43  Device Therapy for Resistant Hypertension
44  Aortic Vascular Interventions (Thoracic and  Abdominal)
45  Venous Intervention
46  Carotid and Cerebrovascular Intervention
47  Stroke Centers and Interventional Cardiology
48  Imaging for Intracardiac Interventions
49  Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defect
50  Left Atrial Appendage Closure and Stroke:  Local Device Therapy for Cardioembolic Stroke  Protection
51  Mitral Valvuloplasty
52  Percutaneous Mitral Valve Repair and  Replacement
53  Balloon-Expandable Transcatheter Aortic Valve  Replacement Systems
54  Self-Expanding Transcatheter Aortic Valve  Replacement
55  Percutaneous Transcatheter Valve-in-Valve  Implantation
56  Pulmonary Valve Interventions
57  Percutaneous Tricuspid Valve Repair
58  Hypertrophic Cardiomyopathy
59  Percutaneous Balloon Pericardiotomy for Patients With Pericardial Effusion and Tamponade
60  Transcatheter Therapies for Congenital Heart  Disease
61  Stem Cell Therapy for Ischemic Heart Disease
62  Percutaneous Treatment of Paravalvular Leak
63  Interventional Heart Failure
64  Qualitative and Quantitative Coronary  Angiography
65  Intravascular Ultrasound
66  The Dynamic Spectrum of Coronary Atheroma: From Atherogenesis to Vulnerable Plaque to Plaque Regression
67  Optical Coherence Tomography
68  Medical Economics in Interventional  Cardiology
69  Quality of Care in Interventional Cardiology
70  Volume and Outcome

About the Author

Eric Topol is one of the most influential cardiologists and scientists in the world, a true "rock star” in cardiology. He is internationally known due to his serving as Editor-in-Chief of Medscape, his numerous multi-million dollar ground-breaking NIH research studies, his widely adopted medical innovations, and his frequent appearances on broadcast television. He is the founding director of the Scripps Translational Institute where large multidisciplinary teams investigate medical innovations in practice, research, and education for the future of medicine.

Because of Dr Topol's incredibly busy schedule and the fact that Dr Teirstein acted as lead editor on the current edition, Dr Topol has proposed a succession plan for the revision, with his colleague Dr Teirstein officially lead editor and the addition of their colleague Dr Price as a second new editor, and a title change from Textbook of Interventional Cardiology to Topol's Textbook of Interventional Cardiology. Paul Teirstein, MD, is Chief of Cardiology, Director of Interventional Cardiology, and Medical Director at the Scripps Prebys Cardiovascular Institute/Scripps Clinic in La Jolla, California.